12 Month Price Forecast For ISRG
Distance to ISRG Price Forecasts
ISRG Price Momentum
🤔 Considering Intuitive Surgical (ISRG)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 8:52 AM UTC
ISRG Analyst Ratings & Price Targets
Based on our analysis of 42 Wall Street analysts, ISRG has a consensus that is bullish. The median price target is $582.50, with forecasts ranging from $265.00 to $700.00. Currently, there are 23 Buy ratings, 9 Hold ratings, and 1 Sell ratings.
With ISRG currently trading at $610.45, the median price forecast suggests a -4.6% downside. The most optimistic forecast comes from at JMP Securities, projecting a 14.7% upside, while Cecilia Furlong at Morgan Stanley provides the most conservative target, suggesting a -56.6% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ISRG Analyst Consensus
ISRG Price Target Range
Latest ISRG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ISRG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 18, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $640.00 |
| Dec 11, 2024 | Citigroup | Joanne Wuensch | Buy | Maintains | $640.00 |
| Dec 11, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $630.00 |
| Dec 5, 2024 | Stifel | Rick Wise | Buy | Maintains | $610.00 |
| Dec 2, 2024 | Morgan Stanley | Cecilia Furlong | Overweight | Upgrade | $650.00 |
| Nov 26, 2024 | BTIG | Ryan Zimmerman | Buy | Maintains | $561.00 |
| Nov 19, 2024 | Erste Group | Hans Engel | Buy | Upgrade | $0.00 |
| Oct 18, 2024 | BTIG | Ryan Zimmerman | Buy | Maintains | $535.00 |
| Oct 18, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $490.00 |
| Oct 18, 2024 | Baird | David Rescott | Outperform | Maintains | $565.00 |
| Oct 18, 2024 | Stifel | Rick Wise | Buy | Maintains | $525.00 |
| Oct 18, 2024 | Piper Sandler | Adam Maeder | Overweight | Reiterates | $538.00 |
| Oct 18, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $549.00 |
| Oct 18, 2024 | RBC Capital | Shagun Singh | Outperform | Maintains | $555.00 |
| Oct 14, 2024 | BTIG | Ryan Zimmerman | Buy | Maintains | $518.00 |
| Oct 14, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $570.00 |
| Oct 14, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $540.00 |
| Oct 11, 2024 | JP Morgan | Robbie Marcus | Overweight | Maintains | $575.00 |
| Oct 8, 2024 | RBC Capital | Shagun Singh | Outperform | Maintains | $525.00 |
| Oct 1, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $475.00 |
Stocks Similar to Intuitive Surgical Inc
The following stocks are similar to Intuitive Surgical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Intuitive Surgical Inc (ISRG) Financial Data
Intuitive Surgical Inc has a market capitalization of $215.17B with a P/E ratio of 97.1x. The company generates $7.87B in trailing twelve-month revenue with a 28.5% profit margin.
Revenue growth is +16.9% quarter-over-quarter, while maintaining an operating margin of +28.3% and return on equity of +16.0%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Intuitive Surgical Inc (ISRG) Company Overview
About Intuitive Surgical Inc
Develops minimally invasive surgical systems and tools.
The company generates revenue by developing, manufacturing, and selling its advanced surgical systems, including the da Vinci Surgical System and Ion endoluminal system. It also offers a suite of support services and digital capabilities that enhance the use of its technology in clinical settings. Sales are primarily made through direct sales organizations, including specialized capital and clinical sales teams.
Intuitive Surgical was founded in 1995 and is headquartered in Sunnyvale, California. The company has established partnerships, such as a collaboration with FluoGuide A/S focused on head and neck cancer, which may expand its market reach and product offerings. Its commitment to enhancing minimally invasive care positions it well within the growing healthcare technology sector.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13,676
CEO
Dr. Gary S. Guthart Ph.D.
Country
United States
IPO Year
2000
Website
www.intuitive.comIntuitive Surgical Inc (ISRG) Latest News & Analysis
Intuitive Surgical (ISRG) produces robotic-assisted surgical devices, notably the da Vinci systems, enhancing minimally invasive surgeries and improving patient outcomes.
Intuitive Surgical's advancements in robotic-assisted surgery enhance patient outcomes, potentially increasing demand for its products and driving future revenue growth, impacting stock performance.
Intuitive Surgical Inc. (NASDAQ: ISRG) issued positive guidance for Q4 2024, bolstered by its da Vinci Surgical System, the first FDA-approved robotic surgical platform since 2000.
Intuitive Surgical's positive guidance signals strong demand for its da Vinci system, potentially boosting revenue and stock performance, indicating confidence in future growth.
Intuitive Surgical's Q4 results are expected to show strong performance in the Instruments & Accessories segment, with improving margins contributing to positive outlook.
Intuitive Surgical's strong fourth-quarter performance and improving margins in Instruments & Accessories suggest potential revenue growth, positively influencing stock valuations and investor sentiment.
Intuitive has acquired a distributor business, enhancing its investment and expanding its presence in the European market.
Intuitive's acquisition enhances its market presence in Europe, potentially increasing revenue streams and competitive advantage, positively influencing stock performance.
Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
3 days agoIntuitive Surgical's Q4 revenue grew 25% YoY, driven by strong procedure volumes and international expansion. The stock price surged, but concerns over valuation remain.
Intuitive Surgical's strong revenue growth and positive outlook on procedures and expansion could lead to continued stock price increases, despite its high valuation.
As of January 21, 2025, four health care stocks may signal caution for momentum-focused investors.
The warning about four health care stocks indicates potential volatility or downturns, signaling momentum traders to reassess risk and adjust their strategies accordingly.
Frequently Asked Questions About ISRG Stock
What is Intuitive Surgical Inc's (ISRG) stock forecast for 2025?
Based on our analysis of 42 Wall Street analysts, Intuitive Surgical Inc (ISRG) has a median price target of $582.50. The highest price target is $700.00 and the lowest is $265.00.
Is ISRG stock a good investment in 2025?
According to current analyst ratings, ISRG has 23 Buy ratings, 9 Hold ratings, and 1 Sell ratings. The stock is currently trading at $610.45. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for ISRG stock?
Wall Street analysts predict ISRG stock could reach $582.50 in the next 12 months. This represents a -4.6% decrease from the current price of $610.45. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Intuitive Surgical Inc's business model?
The company generates revenue by developing, manufacturing, and selling its advanced surgical systems, including the da Vinci Surgical System and Ion endoluminal system. It also offers a suite of support services and digital capabilities that enhance the use of its technology in clinical settings. Sales are primarily made through direct sales organizations, including specialized capital and clinical sales teams.
What is the highest forecasted price for ISRG Intuitive Surgical Inc?
Price targets from Wall Street analysts for ISRG are not currently available. The stock is trading at $610.45.
What is the lowest forecasted price for ISRG Intuitive Surgical Inc?
The lowest price target for ISRG is $265.00 from Cecilia Furlong at Morgan Stanley, which represents a -56.6% decrease from the current price of $610.45.
What is the overall ISRG consensus from analysts for Intuitive Surgical Inc?
The overall analyst consensus for ISRG is bullish. Out of 42 Wall Street analysts, 23 rate it as Buy, 9 as Hold, and 1 as Sell, with a median price target of $582.50.
How accurate are ISRG stock price projections?
Stock price projections, including those for Intuitive Surgical Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
